Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept. [electronic resource]
- PharmacoEconomics 2010
- 935-45 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1179-2027
10.2165/11538370-000000000-00000 doi
Adalimumab Anti-Inflammatory Agents--therapeutic use Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Comparative Effectiveness Research--methods Etanercept Humans Immunoglobulin G--therapeutic use Psoriasis--drug therapy Randomized Controlled Trials as Topic Receptors, Tumor Necrosis Factor--therapeutic use